---
document_datetime: 2023-09-21 17:43:26
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vizamyl-epar-all-authorised-presentations_en.pdf
document_name: vizamyl-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8369512
conversion_datetime: 2025-12-26 17:19:03.334156
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA(EU) Number   | (Invented)   | Strength   | Pharmaceutical Form    | Route of        | Immediate    | Content         | Pack size   |
|-----------------|--------------|------------|------------------------|-----------------|--------------|-----------------|-------------|
|                 | name         |            |                        | Administration  | Packaging    | (concentration) |             |
| EU/1/14/941/001 | VIZAMYL      | 400 MBq/mL | Solution for injection | Intravenous use | vial (glass) | 10 ml           | 1 vial      |
| EU/1/14/941/002 | VIZAMYL      | 400 MBq/mL | Solution for injection | Intravenous use | vial (glass) | 15 ml           | 1 vial      |